| UniProt ID | IPMK_HUMAN | |
|---|---|---|
| UniProt AC | Q8NFU5 | |
| Protein Name | Inositol polyphosphate multikinase | |
| Gene Name | IPMK | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 416 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | Inositol phosphate kinase with a broad substrate specificity. Has a preference for inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol 1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4).. | |
| Protein Sequence | MATEPPSPLRVEAPGPPEMRTSPAIESTPEGTPQPAGGRLRFLNGCVPLSHQVAGHMYGKDKVGILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQPTTTKLNDRTLAEKFLSKGQLSDTEVLEYNNNFHVLSSTANGKIESSVGKSLSKMYARHRKIYTKKHHSQTSLKVENLEQDNGWKSMSQEHLNGNVLSQLEKVFYHLPTGCQEIAEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MATEPPSPL ------CCCCCCCCC | 22.22 | 19369195 | |
| 3 | Phosphorylation | -----MATEPPSPLR -----CCCCCCCCCC | 47.96 | 23186163 | |
| 7 | Phosphorylation | -MATEPPSPLRVEAP -CCCCCCCCCCCCCC | 47.48 | 25159151 | |
| 21 | Phosphorylation | PGPPEMRTSPAIEST CCCCCCCCCCCCCCC | 37.44 | 18691976 | |
| 22 | Phosphorylation | GPPEMRTSPAIESTP CCCCCCCCCCCCCCC | 11.28 | 18691976 | |
| 27 | Phosphorylation | RTSPAIESTPEGTPQ CCCCCCCCCCCCCCC | 43.05 | 17192257 | |
| 28 | Phosphorylation | TSPAIESTPEGTPQP CCCCCCCCCCCCCCC | 16.75 | 17192257 | |
| 32 | Phosphorylation | IESTPEGTPQPAGGR CCCCCCCCCCCCCCC | 19.65 | 27732954 | |
| 72 | Ubiquitination | ILQHPDGTVLKQLQP EEECCCCCCCCCCCC | 30.00 | 22817900 | |
| 113 | Phosphorylation | LRKYLPKYYGIWSPP HHHHCCHHCCCCCCC | 12.65 | - | |
| 114 | Phosphorylation | RKYLPKYYGIWSPPT HHHCCHHCCCCCCCC | 14.30 | - | |
| 118 | Phosphorylation | PKYYGIWSPPTAPND CHHCCCCCCCCCCCC | 21.05 | - | |
| 136 | Ubiquitination | KLEDVTHKFNKPCIM EHHHCCHHCCCCEEE | 41.07 | 29967540 | |
| 139 | Ubiquitination | DVTHKFNKPCIMDVK HCCHHCCCCEEEEEE | 44.38 | 29967540 | |
| 150 | Ubiquitination | MDVKIGQKSYDPFAS EEEEECCCCCCCCCC | 45.85 | 29967540 | |
| 160 | Ubiquitination | DPFASSEKIQQQVSK CCCCCHHHHHHHHHC | 48.00 | 22817900 | |
| 163 | Ubiquitination | ASSEKIQQQVSKYPL CCHHHHHHHHHCCHH | 49.46 | 22817900 | |
| 208 | Acetylation | SLTKETIKDGVSRFF CCCHHHHHHHHHHHH | 56.71 | 19817419 | |
| 223 | Ubiquitination | HNGYCLRKDAVAASI CCCEECCHHHHHHHH | 36.77 | 29967540 | |
| 229 | Phosphorylation | RKDAVAASIQKIEKI CHHHHHHHHHHHHHH | 18.80 | - | |
| 232 | Acetylation | AVAASIQKIEKILQW HHHHHHHHHHHHHHH | 51.68 | 25953088 | |
| 232 | Ubiquitination | AVAASIQKIEKILQW HHHHHHHHHHHHHHH | 51.68 | 29967540 | |
| 251 | Phosphorylation | KQLNFYASSLLFVYE HHHEEEEEEEEEEEC | 15.33 | 22468782 | |
| 252 | Phosphorylation | QLNFYASSLLFVYEG HHEEEEEEEEEEECC | 22.41 | 22468782 | |
| 257 | Phosphorylation | ASSLLFVYEGSSQPT EEEEEEEECCCCCCC | 13.77 | 22468782 | |
| 266 | Phosphorylation | GSSQPTTTKLNDRTL CCCCCCCCCCCHHHH | 35.69 | - | |
| 312 | Acetylation | KIESSVGKSLSKMYA EEECCHHHHHHHHHH | 46.17 | 25953088 | |
| 312 | Ubiquitination | KIESSVGKSLSKMYA EEECCHHHHHHHHHH | 46.17 | 29967540 | |
| 315 | O-linked_Glycosylation | SSVGKSLSKMYARHR CCHHHHHHHHHHHHH | 23.59 | 30379171 | |
| 318 | Phosphorylation | GKSLSKMYARHRKIY HHHHHHHHHHHHHHH | 12.29 | - | |
| 325 | Phosphorylation | YARHRKIYTKKHHSQ HHHHHHHHCCCCCCC | 18.62 | - | |
| 333 | Phosphorylation | TKKHHSQTSLKVENL CCCCCCCCEEEEEEC | 38.76 | - | |
| 334 | Phosphorylation | KKHHSQTSLKVENLE CCCCCCCEEEEEECH | 20.68 | - | |
| 348 | Phosphorylation | EQDNGWKSMSQEHLN HHCCCCHHCCHHHHC | 19.70 | 19369195 | |
| 350 | Phosphorylation | DNGWKSMSQEHLNGN CCCCHHCCHHHHCCC | 39.24 | 27050516 | |
| 360 | Phosphorylation | HLNGNVLSQLEKVFY HHCCCHHHHHHHHHH | 28.56 | - | |
| 367 | Phosphorylation | SQLEKVFYHLPTGCQ HHHHHHHHHCCCCCH | 12.87 | 27642862 | |
| 412 | Phosphorylation | HLISVLRSILDN--- HHHHHHHHHHCC--- | 24.28 | 17081983 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of IPMK_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of IPMK_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of IPMK_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of IPMK_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; THR-21; SER-22;SER-348 AND SER-350, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND MASSSPECTROMETRY. | |